US FDA issues alert on study of Abbott antibiotic (Reuters)


Reuters - U.S. regulators alerted the public
on Friday to a study showing a higher death rate among heart
disease patients a year after taking an Abbott Laboratories
Inc. antibiotic, as part of an effort to release early
information about potential safety concerns.